skip to Main Content

Sight is vital to our health and well-being.

In fact, people fear vision loss more than losing hearing, memory, speech or even a limb. Vision research is helping every day — producing exciting new insights about eye disease, developing innovations to restore sight, and driving clinical breakthroughs that are helping all of us see the future more clearly.

VRMWG Protect Your Vision Rest - Purple diagram with eye in upper right and text

DED can cause pain, blurriness, and inflammation, can even injure your cornea, and recent studies demonstrate that the damage doesn’t stop there. They reveal that individuals with DED find it harder to perform simple tasks such driving or getting dressed; experience significant pain that interferes with social relationships; and report increased anxiety, depression, and poor overall health. Experts estimate that more than 340 million adults globally and 34 million in the United States live with this condition.

More Stories

David A. Antonetti, PhD, is the Roger W. Kittendorf Research Professor of Ophthalmology and Visual Sciences at the University of Michigan Kellogg Eye Center. His research areas include angiogenesis and vascular diseases as well as diabetes and metabolic disorders. More specifically, he investigates the formation and loss of the blood-brain and blood-retinal barriers with the goal of developing new treatments for diabetes-related vision loss.

More Visionaries

“Glaucoma: Clinical Practice and Research to Optimize Patient Outcomes,” March 11, 12:00pm ET

This Congressional Briefing, from AEVR’s Research Saving Sight, Restoring Vision initiative, will feature clinician scientist-educators Mona Kaleem, MD and Elyse Joelle McGlumphy, MD, who will speak about glaucoma and their respective clinical experiences in treating patients, as well as their research efforts to better understand and optimize the patient experience. For more information, download the flyer (PDF).

Register Here

VISION RESEARCH IS AN INVESTMENT IN A BETTER FUTURE

As NIH Director Frances Collins put it, “Due to the architecture, accessibility, and the elegance of the eye, vision research has always been a few steps ahead in biomedical research.”

Back To Top